Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from PW Medtech Group Ltd. ( (HK:1358) ) is now available.
PW Medtech Group Limited has declared a final ordinary cash dividend of HKD 0.02 per share for the financial year ended 31 December 2025, reflecting its decision to return cash to shareholders. The dividend is subject to shareholder approval on 26 June 2026, with the shares trading ex-dividend on 2 July 2026, a record date of 8 July 2026, and payment scheduled for 31 July 2026, signaling continued capital distribution and providing income visibility for investors.
The entitlement period will be determined via a book closure from 6 July to 8 July 2026, during which share transfers must be completed by 3 July 2026 to qualify for the payout. The announcement also confirms the current composition of the company’s board, underscoring established governance as the firm continues its shareholder return policy without any withholding tax applied to this dividend.
The most recent analyst rating on (HK:1358) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on PW Medtech Group Ltd. stock, see the HK:1358 Stock Forecast page.
More about PW Medtech Group Ltd.
PW Medtech Group Limited is a Hong Kong-listed company in the healthcare and medical technology sector. It focuses on providing medical products and related services, targeting hospitals, clinics, and other healthcare institutions in its key markets, and its shares are traded on the Main Board of the Hong Kong Stock Exchange under stock code 01358.
Average Trading Volume: 713,658
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.49B
For a thorough assessment of 1358 stock, go to TipRanks’ Stock Analysis page.